| | | | | |
AGIO Agios Pharmaceuticals, Inc. | €24,5617 | +3,25% | €1,50B | €64,92K | |
SGRY Surgery Partners, Inc. Common Stock | €11,9371 | +2,81% | €1,50B | €217,18K | |
GAB The Gabelli Equity Trust Inc. | €4,8169 | -0,09% | €1,50B | €304,66K | |
HURN Huron Consulting Group Inc. | €92,3898 | +2,58% | €1,49B | €11,66K | |
ENVX Enovix Corporation Common Stock | €7,0488 | -0,34% | €1,49B | €1,68M | |
PAYO Payoneer Global Inc. Common Stock | €4,5488 | +3,99% | €1,49B | €679,82K | |
ETV Eaton Vance Tax-Managed Buy-Write Opportunities Fund | €12,8137 | +0,00% | €1,49B | €41,31K | |
STGW Stagwell Inc. Class A Common Stock | €5,8654 | +3,57% | €1,49B | €133,06K | |
CASH Pathward Financial, Inc. Common Stock | €67,9356 | +1,69% | €1,49B | €30,02K | |
SNDX Syndax Pharmaceuticals, Inc. | €15,4735 | -1,83% | €1,49B | €3,19M | |
STRA Strategic Education, Inc. Common Stock | €69,9552 | +2,97% | €1,49B | €31,70K | |
CAPR Capricor Therapeutics Inc | €24,1835 | +1,81% | €1,49B | €89,08K | |
AAPG Ascentage Pharma Group International American Depository Shares | €15,8637 | +3,30% | €1,48B | €1,34K | |
SLS SELLAS Life Sciences Group, Inc. Common Stock | €7,4553 | +5,92% | €1,48B | €2,02M | |
PLSE Pulse Biosciences, Inc Common Stock (DE) | €23,8956 | +11,27% | €1,48B | €212,85K | |
